A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

NCT00832546 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hyperalgesia

Interventions

DRUG: Placebo
DRUG: Oral NGX426 (Powder in solution)

Sponsor

TorreyPines Therapeutics